COMPREHENSIVE SARS-COV-2 VARIANT DETERMINATION USING NEXT-GENERATION SEQUENCING (NGS)

Need to better understand and track known and emerging variants of the COVID-19 virus?

The Importance of Genomic Surveillance for SARS-CoV-2 Variants

Progressively more and more cases of COVID-19 across the US are being caused by variants of the SARS-CoV-2- virus. These shifts can not only make the virus more contagious or result in more severe symptoms than the original NCBI Reference Sequence NC_045512.2 Wuhan-Hu-1, but they can also render newly developed vaccines ineffective.

As a result, public health officials and other local authorities have an increased need—and responsibility—to understand how the virus is evolving its transmission and progression.

HAVE QUESTIONS ABOUT NGS-BASED MUTATION PROFILES?
Ask us how we can help you get the data you need for public health surveillance and research-based applications.

How is the Government Tracking Virus Variants?

State health departments and other organizations began sending patient samples for variant sequencing and characterization in November 2020. Today, the Center for Disease Control (CDC) is increasing those efforts through its national SARS-CoV-2 strain surveillance (NS3) program.

By collaborating with independent sequencing facilities like ours, public health stakeholders can process a larger volume and wider variety of specimens faster.

How Can You Contribute to Variant Surveillance?

If you are looking for a way to understand how COVID-19 variants might be changing or are looking for the best way to obtain sequence data for submission to public repositories like the CDC’s NS3 program, we can help.

The Key to Good Surveillance is Good Tracking

Since the first case of COVID-19 was discovered, scientists knew that it would mutate. They also knew that one of the biggest challenges they would face while sequencing and characterizing SARS-CoV-2 variants is ensuring their methods are accurate

Our team has partnered with Swift Biosciences to implement the Swift Normalase®️ Ampicon SARS-CoV-2 Panel (SNAP), which facilitates up to 99.7% coverage of the SARS-CoV-2 genome, into our sequencing workflow. 

That means the method is very accurate. According to Swift Biosciences’ team: If there is a variant, you will see it.

SNAP Sequencing Workflow

We handle everything—end-to-end. Here’s how it works.

Looking for more details about the SNAP research panel?

Want to see what your data will look like?

Why Psomagen

Our team is accredited to perform the highest quality research and are proven experts in next-generation sequencing. Because our labs are US-based, your valuable samples never leave the country. That means we can better protect their stability and integrity and deliver results quickly.

24-Year Sequencing History

24-Year Sequencing History

US-Based Labs

US-Based Labs

>2 Week Turnaround

Less Than 2 Week Turnaround

HERE’S WHAT OUR CUSTOMERS ARE SAYING

 

SERVICE CAN’T BE BEAT

I’ve done a lot of shopping around, and Posmangen products and service can’t be beat.

  • Diagnostics Provider

TURNAROUND TIME = AMAZING

I was very impressed with the customer service that I received. The representative responded quickly and with succinct information. The turnaround time was also amazing. I definitely had a good experience with Psomagen.

  • Lead Academic Administrator

Get the information you need to help control the spread of COVID-19.